Finally, increased IL-8 expression and CAC were found to be independent predictors of overall survival, and hence measuring serum IL-8 levels is suggested for evaluating the prognosis of patients with pancreatic cancer, while further studies are required to assess the therapeutic potential of IL-8 inhibition [26]. The gene discussed is CXCL8; the disease is familial pancreatic carcinoma.